STOCK TITAN

PUBLIC COMPANY MGMT CORP 10-Q Filings

PCMC OTC

Every 10-Q that PUBLIC COMPANY MGMT CORP (PCMC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow PCMC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PCMC filings page.

Rhea-AI Summary

Public Company Management Corporation reports that it remains a non‑operating shell with no revenues for the three and nine months ended June 30, 2026 and a net loss of $115,690 for the nine‑month period, compared with a loss of $67,356 a year earlier. General and administrative expenses more than doubled year over year to $117,498, driven largely by higher professional fees.

Liquidity is very limited: cash was $6,692 and total assets were $6,692 at June 30, 2026, against current liabilities of $329,543, resulting in a working capital deficit of $322,851. The company carries a related‑party note payable to Specialty Capital Lenders LLC of $279,484, maturing December 31, 2026, after a February 2026 restructuring that reduced principal and eliminated previously accrued interest.

Auditors and management highlight substantial doubt about the company’s ability to continue as a going concern, and management concludes that disclosure controls and internal control over financial reporting are not effective. To address its status as a shell, the company has signed a Share Exchange Agreement to acquire Physicians Capital Management Corporation, a healthcare real estate platform. If completed, Physicians’ shareholders are expected to own about 80% of the combined company through 68,566,368 new common shares and 24,913,918 preferred shares, significantly diluting current holders.

Rhea-AI Summary

Public Company Management Corporation remains a non-operating shell focused on finding a business combination. For the three months ended March 31, 2026, it generated no revenue and recorded a net loss of $74,107; the six-month loss was $91,130. Operating expenses rose sharply year over year due mainly to higher professional fees for audits.

Cash fell from $234,405 at September 30, 2025 to $15,052 at March 31, 2026, leaving a working capital deficit of $298,291 and an accumulated deficit of $5,827,307. The company restructured a related-party promissory note, reducing principal from $350,000 to $279,484 and temporarily suspending interest accrual, but it still depends on related parties for funding.

Management and the auditors highlight substantial doubt about the company’s ability to continue as a going concern. Internal control over financial reporting and disclosure controls were concluded to be not effective. The company reports preliminary discussions by its majority shareholder that could lead to a change in control and a potential future business combination, although no specific transaction is in place.

Rhea-AI Summary

Public Company Management Corporation reported another loss for the quarter ended December 31, 2025, while remaining a shell company seeking a business combination. The company generated no revenue and recorded a net loss of $17,023, slightly improved from a restated loss of $20,337 a year earlier.

At December 31, 2025, total assets were $256,744, including cash of $71,555 and a note receivable of $163,000 from Physicians Capital Management Corporation, with accrued interest receivable of $2,189. Liabilities totaled $480,928, driven mainly by a related-party promissory note of $350,000 accruing 3% interest and related accrued interest of $97,154.

The company had a stockholders’ deficit of $224,184 and an accumulated deficit of $5,753,200, and its auditors and management highlight substantial doubt about its ability to continue as a going concern. Operations are funded by related parties, including Repository Services LLC and Specialty Capital Lenders LLC. Management is focused on completing a business combination and is in substantive negotiations with Physicians Capital Management Corporation, a healthcare real estate company, though no definitive agreement or letter of intent has been signed.